Dicyclomine Hydrochloride
- Product NDC
- 68071-4782
- 11-digit product format
- 680714782
- Labeler code
- 68071
- Product ID
- 68071-4782_21f06630-bb01-ed32-e063-6294a90ac95b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dicyclomine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA040230
- Marketing category
- ANDA
- Marketing start
- 1999-02-26
- Substance
- DICYCLOMINE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dicyclomine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DICYCLOMINE HYDROCHLORIDE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CQ903KQA31 |
| Rxcui | 991086 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-4782-1 | 2024-06-14 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-2 | 2024-06-14 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-3 | 2024-06-14 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-6 | 2024-06-14 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-9 | 2024-06-14 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-1 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-2 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-9 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-3 | 2021-03-24 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
| 68071-4782-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3b04-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-4782-1 | Dicyclomine Hydrochloride | 10 in 1 BOTTLE | TABLET | 10 | | 5 |
| 68071-4782-2 | Dicyclomine Hydrochloride | 20 in 1 BOTTLE | TABLET | 20 | | 5 |
| 68071-4782-3 | Dicyclomine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 68071-4782-6 | Dicyclomine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | | 5 |
| 68071-4782-9 | Dicyclomine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-4782 | DICYCLOMINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 5 | Current NDC, Legacy NDC, 5 package rows | 20240913_82832a91-d16c-3a63-e053-2a91aa0a3ffb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4782-1 | 68071478201 | 10 TABLET in 1 BOTTLE (68071-4782-1) | 10 tablet | 2019-02-22 | 0000-00-00 | No | No | Current |
| 68071-4782-2 | 68071478202 | 20 TABLET in 1 BOTTLE (68071-4782-2) | 20 tablet | 2019-02-22 | 0000-00-00 | No | No | Current |
| 68071-4782-3 | 68071478203 | 30 TABLET in 1 BOTTLE (68071-4782-3) | 30 tablet | 2019-02-22 | 0000-00-00 | No | No | Current |
| 68071-4782-6 | 68071478206 | 60 TABLET in 1 BOTTLE (68071-4782-6) | 60 tablet | 2019-02-22 | 0000-00-00 | No | No | Current |
| 68071-4782-9 | 68071478209 | 90 TABLET in 1 BOTTLE (68071-4782-9) | 90 tablet | 2019-02-22 | 0000-00-00 | No | No | Current |